HAMPTON, N.H.--(BUSINESS WIRE)--Jan. 25, 2006--Frank H. Jellinek
Jr., chairman emeritus of Fisher Scientific International Inc. (NYSE:
FSH), died yesterday morning in a tragic plane crash at the
McClellan-Palomar Airport in Carlsbad, Calif. Jellinek, 60, is
survived by his wife, Judy, two children and two grandchildren.
"All of us at Fisher are deeply saddened by the loss of our good
friend. Our heartfelt sympathy and prayers go out to Frank's family,"
said Paul M. Montrone, chairman and chief executive officer of Fisher
Scientific International. "Frank was a great leader and an outstanding
person who dedicated his life to his family, company and community.
Everyone who knew and worked with him was impressed by his passion for
the business and his warm personality. He will be greatly missed."
Jellinek was appointed chairman emeritus following the 2004 merger
of Apogent Technologies and Fisher Scientific International. Prior to
the merger, he served as chairman and chief executive officer of
Apogent Technologies.
Jellinek was a veteran in the scientific-research industry with
more than 40 years of experience. In 1962, at the age of 15, he began
working at Erie Scientific, a microscope slide company his grandfather
founded.
Erie Scientific was sold to Sybron Corporation in 1969 and
Jellinek remained with the company, eventually becoming president of
Sybron in 1998. In 2000, Sybron changed its name to Apogent
Technologies, and Jellinek was named president and CEO.
Born in Buffalo, N.Y., Jellinek earned a bachelor's degree in
business administration from Miami University in Ohio and an MBA from
Canisius College in New York.
Fisher Scientific: A World Leader in Serving Science
Fisher Scientific International Inc. (NYSE: FSH) is a leading
provider of products and services to the scientific community. Fisher
facilitates discovery by supplying researchers and clinicians in labs
around the world with the tools they need. We serve pharmaceutical and
biotech companies; colleges and universities; medical-research
institutions; hospitals; reference, quality-control, process-control
and R&D labs in various industries; as well as government agencies.
From biochemicals, cell-culture media and proprietary RNAi technology
to rapid-diagnostic tests, safety products and other consumable
supplies, Fisher provides more than 600,000 products and services.
This broad offering, combined with Fisher's globally integrated supply
chain and unmatched sales and marketing presence, helps make our
350,000 customers more efficient and effective at what they do.
Founded in 1902, Fisher Scientific is a FORTUNE 500 company and is
a component of the S&P 500 Index. Fisher Scientific is a company
committed to high standards and delivering on our promises -- to
customers, shareholders and employees alike. Additional information
about Fisher is available on the company's Web site at
www.fisherscientific.com.
CONTACT: Fisher Scientific International Inc.
Media Contact:
Gia L. Oei, 603-929-2489
Gia.Oei@fishersci.com
or
Investor Contact:
Chet Mehta, 603-929-2260
Chet.Mehta@fishersci.com
SOURCE: Fisher Scientific International Inc.
